Skip to main content
. 2020 May 8;11:664. doi: 10.3389/fphar.2020.00664

Table 1.

Baseline clinical and pathological characteristics of the 87 patients enrolled in the study.

Patient characteristics Category/Class Count (n=24) Rate (%)
Age (y), median (range) 57(29–77)
Gender Female 52 59.8
Male 35 40.2
Body weight 57(37–82.5)
BSA (m2) 1.59(1.24–1.92)
Smoking status Never 57 65.5
Former 16 18.4
Present 14 16.1
Clinical stage (UICC) III 24 27.6
IV 63 72.4
ECOG PS 0 34 39.1
1 48 55.2
2 5 5.7
EGFR mutation status Exon 19 deletion 58 66.7
Exon 21 L858R 29 33.3

BSA, body surface area; ECOG PS, eastern cooperative oncology group performance status; EGFR, epidermal growth factor receptor.